88 related articles for article (PubMed ID: 17961733)
1. Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models.
Grabowska AM; Morris TM; McKenzie AJ; Kumari R; Hamano H; Emori Y; Yoshinaga K; Watson SA
Regul Pept; 2008 Feb; 146(1-3):46-57. PubMed ID: 17961733
[TBL] [Abstract][Full Text] [Related]
2. Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro.
Kawasaki D; Emori Y; Eta R; Iino Y; Hamano H; Yoshinaga K; Tanaka T; Takei M; Watson SA
Cancer Chemother Pharmacol; 2008 Apr; 61(5):883-92. PubMed ID: 17901954
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor.
Dickson JH; Grabowska A; El-Zaatari M; Atherton J; Watson SA
Cancer Res; 2006 Aug; 66(15):7524-31. PubMed ID: 16885350
[TBL] [Abstract][Full Text] [Related]
4. [Gastrin-17 and G17-gly induce proliferation of LoVo cells through the CCK B/gastrin receptor].
Artru P; Attoub S; Levasseur S; Lewin MJ; Bado A
Gastroenterol Clin Biol; 1998; 22(6-7):607-12. PubMed ID: 9762332
[TBL] [Abstract][Full Text] [Related]
5. [Blocking the gastrin/cholecystokinin-B receptor autocrine loop influences the growth and apoptosis of human gastric cancer cells].
Wang WL; Zhou JJ; Zhou XC; Yang XF
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1989-92. PubMed ID: 17064598
[TBL] [Abstract][Full Text] [Related]
6. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
7. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines.
Savage K; Waller HA; Stubbs M; Khan K; Watson SA; Clarke PA; Grimes S; Michaeli D; Dhillon AP; Caplin ME
Int J Oncol; 2006 Dec; 29(6):1429-35. PubMed ID: 17088981
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological evaluation of analgesic effects of the cholecystokinin2 receptor antagonist Z-360 in mouse models of formalin- and cancer-induced pain.
Yoshinaga K; Horii T; Hamano H; Eta R; Ozaki T; Orikawa Y; Yoshii K; Kawabata Y; Hori Y; Seto K; Takei M; Kuraishi Y
Biol Pharm Bull; 2010; 33(2):244-8. PubMed ID: 20118547
[TBL] [Abstract][Full Text] [Related]
9. CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells.
Kato H; Seto K; Kobayashi N; Yoshinaga K; Meyer T; Takei M
Life Sci; 2011 Oct; 89(17-18):603-8. PubMed ID: 21839751
[TBL] [Abstract][Full Text] [Related]
10. rG17PE38, a novel immunotoxin target to gastric cancer with overexpressed CCK-2R.
Song J; Ren H; Li Y; Xu J; Kong H; Tong W; Zhou Y; Gao S; Liu Y; Hui Q; Peng Q; Lu S; Liu Z
J Drug Target; 2013 May; 21(4):375-82. PubMed ID: 23311704
[TBL] [Abstract][Full Text] [Related]
11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer.
Rai R; Chandra V; Tewari M; Kumar M; Shukla HS
Surg Oncol; 2012 Dec; 21(4):281-92. PubMed ID: 22801592
[TBL] [Abstract][Full Text] [Related]
13. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
[TBL] [Abstract][Full Text] [Related]
14. Z-360, a novel cholecystokinin-2/gastrin receptor antagonist, inhibits gemcitabine-induced expression of the vascular endothelial growth factor gene in human pancreatic cancer cells.
Kobayashi N; Seto K; Orikawa Y; Hamano H; Yoshinaga K; Takei M
Biol Pharm Bull; 2010; 33(2):216-22. PubMed ID: 20118543
[TBL] [Abstract][Full Text] [Related]
15. Importance of N- and C-terminal regions of gastrin-Gly for preferential binding to high and low affinity gastrin-Gly receptors.
Ahmed S; Murphy RF; Lovas S
Peptides; 2005 Jul; 26(7):1207-12. PubMed ID: 15949639
[TBL] [Abstract][Full Text] [Related]
16. Blockade of cholecystokinin-2 receptor and cyclooxygenase-2 synergistically induces cell apoptosis, and inhibits the proliferation of human gastric cancer cells in vitro.
Sun WH; Zhu F; Chen GS; Su H; Luo C; Zhao QS; Zhang Y; Shao Y; Sun J; Zhou SM; Ding GX; Cheng YL
Cancer Lett; 2008 May; 263(2):302-11. PubMed ID: 18258354
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a fluorescent non-peptidic cholecystokinin-B/gastrin receptor specific antagonist for cancer cell imaging.
Kumari S; Chowdhury J; Mishra AK; Chandna S; Saluja D; Chopra M
Chembiochem; 2012 Jan; 13(2):282-92. PubMed ID: 22162268
[TBL] [Abstract][Full Text] [Related]
18. Gastrin 1-6 promotes growth of colon cancer cells through non-CCK receptors.
Copps J; Ahmed S; Murphy RF; Lovas S
Peptides; 2007 Mar; 28(3):632-5. PubMed ID: 17126952
[TBL] [Abstract][Full Text] [Related]
19. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
[TBL] [Abstract][Full Text] [Related]
20. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
